Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002933015 | SCV003263355 | likely benign | not provided | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004067053 | SCV003880563 | uncertain significance | not specified | 2023-01-09 | criteria provided, single submitter | clinical testing | The c.1264T>G (p.F422V) alteration is located in exon 6 (coding exon 3) of the CASZ1 gene. This alteration results from a T to G substitution at nucleotide position 1264, causing the phenylalanine (F) at amino acid position 422 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |